Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13–ETA′ and the bispecific scFv [13xds16]

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-017-2468-5PMID 28669053PMCID PMC11819209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.

  2016cited by this paper
• Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies

  2016cited by this paper
• Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo.

  2016cited by this paper
• Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer

  2016cited by this paper
• Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.

  2015cited by this paper
• Advances in anticancer immunotoxin therapy.

  2015cited by this paper
• Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line

  2015cited by this paper
• The Fc‐alpha receptor is a new target antigen for immunotherapy of myeloid leukemia

  2015cited by this paper
• Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities

  2015cited by this paper
• Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo

  2015cited by this paper
• Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.

  2014cited by this paper
• A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

  2014cited by this paper
• An EGFR/CD13 bispecific fusion protein and its enediyne-energized analog show potent antitumor activity

  2014cited by this paper
• World cancer report 2014.

  2014cited by this paper
• Multimerization of anti‐(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers

  2013cited by this paper
• Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo

  2013cited by this paper
• Immunotoxins: The Role of the Toxin †

  2013cited by this paper
• In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments

  2013cited by this paper
• CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis

  2013cited by this paper
• Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model

  2013cited by this paper
• A recombinant triplebody with specificity for CD19 and HLA-DR mediates 
preferential binding to antigen double-positive cells by dual-targeting

  2012cited by this paper
• Antibody therapy of cancer

  2012cited by this paper
• In vivo efficacy of the recombinant anti‐CD64 immunotoxin H22(scFv)‐ETA′ in a human acute myeloid leukemia xenograft tumor model

  2011cited by this paper
• Aminopeptidase‐N/CD13 is a potential proapoptotic target in human myeloid tumor cells

  2011cited by this paper
• Aminopeptidase N (CD13) as a target for cancer chemotherapy

  2011cited by this paper
• CD13 is a therapeutic target in human liver cancer stem cells.

  2010cited by this paper
• Effective Elimination of Acute Myeloid Leukemic Cells by Recombinant Bispecific Antibody Derivatives Directed Against CD33 and CD16

  2010cited by this paper
• Novel conjugates of single‐chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells

  2010cited by this paper
• A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells

  2008cited by this paper
• The moonlighting enzyme CD13: old and new functions to target

  2008cited by this paper
• Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

  2008cited by this paper
• A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells

  2008cited by this paper
• Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors

  2007cited by this paper
• Immunotoxin treatment of cancer.

  2007cited by this paper
• Immunotoxins for targeted cancer therapy

  2006cited by this paper
• Effective lysis of lymphoma cells with a stabilised bispecific single‐chain Fv antibody against CD19 and FcγRIII (CD16)

  2005cited by this paper
• Aminopeptidase‐N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects

  2005cited by this paper
• Antigen targeting to dendritic cells with bispecific antibodies.

  2005cited by this paper
• NK cells: innate immunity against hematological malignancies?

  2004cited by this paper
• A recombinant bispecific single‐chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells

  2004cited by this paper
• Clonal Analysis of a Human Antimouse Antibody (HAMA) Response

  2003cited by this paper
• Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.

  2003cited by this paper
• Fc receptor biology.

  2003cited by this paper
• High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.

  2002cited by this paper
• Compatible-Solute-Supported Periplasmic Expression of Functional Recombinant Proteins under Stress Conditions

  2000cited by this paper
• Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

  2000cited by this paper
• Immunotoxins for targeted cancer therapy.

  1998cited by this paper
• Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay.

  1997cited by this paper
• Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system.

  1997cited by this paper
• Biotechnological and gene therapeutic strategies in cancer treatment.

  1995cited by this paper
• Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand.

  1994cited by this paper

• Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles.

  2025cites this paper
• Engineering scFv immunotherapies: From CAR T cells to bispecific antibodies.

  2025cites this paper
• The Role of the Ectopeptidase APN/CD13 in Cancer

  2023cites this paper
• Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives

  2022cites this paper
• Emerging trends in immunotoxin targeting cancer stem cells.

  2022cites this paper
• CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner

  2021cites this paper
• Computational study of novel natural inhibitors targeting aminopeptidase N(CD13)

  2020cites this paper
• Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity

  2020cites this paper
• Antibody-Based Targeted Therapy: A Novel Cancer Treatment

  2020cites this paper
• CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110

  2020cites this paper
• Distinct Epitopes on CD13 Mediate Opposite Consequences for Cell Adhesion

  2018cites this paper
• Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

  2017cites this paper
• CD10 and the nail

  2017cites this paper